Dr. Mohammad Samir Alghussein, MD

Dr. Alghussein practices at UCLA West Valley Medical Center in West Hills, California, part of University of California Health.

Dr. Alghussein's NPI, 1255780185, was assigned on June 10, 2016. Dr. Alghussein holds Illinois license 125068351.

Dr. Alghussein's primary practice is UCLA West Valley Medical Center, at 7300 Medical Center Dr, West Hills, CA 91307 in Los Angeles County. The practice phone is (818) 676-4000.

Dr. Alghussein's primary practice is UCLA West Valley Medical Center in West Hills, California, part of University of California Health. Dr. Alghussein is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Alghussein to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alghussein practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Alghussein's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Alghussein's licenses on file in 2 states: Illinois and California.

CMS data shows 1,069 Medicare services from Dr. Alghussein across 7 procedure codes in 2024, for 409 Medicare patients. Medicare paid $106,705 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 409 Medicare patients who saw Dr. Alghussein in 2024. The largest group is 75 to 84, with 161 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alghussein's median patient age at 63, with 46% women.

In 2024, Dr. Alghussein wrote 114 Medicare Part D claims for 51 patients. 89% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $105 in total drug cost. In 2023, CMS named 112 claims across 5 drugs.

Dr. Alghussein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Alghussein from 2 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Relypsa, Inc. paid the most, $25.